Three Pillars to Eliminate Cancer Disparities
“...Community engagement is the process of working collaboratively with and through groups of people affiliated by geographic proximity, special interest, or similar situations to address issues affecting the well-being of those people.” (CDC, 1997). Successful partnerships merge together to mobilize resources, influence systems, change relationships among partners, and serve as catalysts for changing policies, programs, and practices (Fawcett et al., 1995). More The community engagement activities of the SCI-CPP include support for local community based health events and expertise in planning cancer prevention and control activities. The activities will emphasize cancer prevention where possible, and cancer risk reduction where preventive actions have yet to be described. Our overarching goal in community engagement is to develop sustainable and long-term relationships with the surrounding communities of the Greater Bay Area and to facilitate CBPR and increase participation of underserved populations in design and benefits of cancer clinical trials.
Community Engaged & Community-Based Participatory Research
Community-based Participatory Research (CBPR)“...[is] a collaborative approach to research that...involves all partners in the research process and recognizes the unique strengths that each [partner] brings” (W.K. Kellogg Foundation, 2001). CBPR begins with a community-identified research topic of importance. The impact of CBPR is realized by combining collaborative knowledge and action to achieve social change; improve health outcomes; and eliminate health disparities. More CBPR requires inputs from the community and academic partners from project inception to implementation, and completion of deliverables. Community engaged research (CEnR) is an approach for conducting research that is guided by the identified needs of the communities. The research, although driven by community needs, is largely conducted by the academic partner with ongoing input from the community partner. Therefore, the success of the research depends on the relationship between the two. The SCI-CPP works to facilitate both CBPR and CEnR projects, finding and matching academic and community partners with joint cancer interests and concerns.
Fawcett, S. B., Paine-Andrews, A., Francisco, V. T., Schultz, J. A., Richter, K. P., Lewis, R. K., ... & Lopez, C. M. (1995). Using empowerment theory in collaborative partnerships for community health and development. American journal of community psychology, 23(5), 677-697.
W.K. Kellogg Foundation (2001). Kellogg Health Scholars Program Community Track. Available at www.kellogghealthscholars.org/about/community.cfm, Last accessed January 6, 2014.
Increasing Minority Participation in Cancer Clinical Trials
Cancer clinical trials play an important role in developing new interventions to prevent, diagnose and treat all types of cancer. Racial/ethnic diversity in cancer clinical trials is critical to the development of therapies which are effective in all populations. Although 1 in 5 of all patients with cancer are eligible to participate in a clinical trial, only 1 in 30 are successfully enrolled. Among those who participate in trials, fewer than 5% are racial or ethnic minorities. More Broadening racial/ethnic participation in cancer clinical trials is a top priority for SCI-CPP. Through our community engagement activities we hope to gain a better understanding of the knowledge and attitudes about cancer clinical trials in our Greater Bay Area communities. Armed with this information, SCI-CPP will work collaboratively with the Stanford Clinical Trials Office to increase participation of racial/ethnic minorities to ensure that the results of the studies are relevant to the diverse populations in our catchment area.